Abstract:Abstract Increased susceptibility to DNA damage has been shown to be associated with increased risk of many cancers. Accumulation of gamma-H2AX (γ-H2AX) in cultured cells after stimulation by ionizing radiation or other genotoxic agents is a sensitive indicator of DNA double-strand breaks (DSBs) induction. We hypothesize that higher level of DSBs, as measured by γ-H2AX levels in peripheral blood lymphocytes (PBLs), may be able to predict higher cancer risk. We first developed an objective, high-throughput, and image-based method to quantify immunofluorescence intensities of γ-H2AX in cultured PBLs. To test this hypothesis, using an ongoing esophageal cancer case control study, we measured the γ-H2AX levels at baseline and after gamma-radiation in the PBLs from 245 newly diagnosed, previously untreated esophageal cancer patients and 400 healthy control subjects, and calculated the ratio of radiation-induced to the baseline γ-H2AX levels as a parameter of DSBs. The mean γ-H2AX ratio was significantly higher in cases (1.48±0.14) than controls (1.39±0.11) (P =1.47×10-14). When dichotomized at the median level of the γ-H2AX ratio in control subjects, individuals in the high γ-H2AX ratio group exhibited a significantly increased risk of esophageal cancer (odds ratio [OR]=2.83, 95% confidence intervals [CI]: 2.00-4.00). When subjects were categorized into tertiles defined by the distribution of the relative γ-H2AX ratio in control subjects, a significant dose-response relationship was observed between γ-H2AX ratio and risk of esophageal cancer. Compared to subjects in the lowest tertile of γ-H2AX ratio, those in the middle and the highest tertiles exhibited increased risks of esophageal cancer with ORs of 1.60 (95% CI: 1.00-2.55) and 3.72 (95% CI: 2.43-5.70), respectively (P for trend =2.24×10-10). Quartile analysis also showed similar dose-response relationship. Our data suggest that higher ratio of gamma-radiation-induced to baseline γ-H2AX is significantly associated with an increased risk of esophageal cancer. This study supports that measurement of this ratio may be used as a novel phenotypic assay to identify individuals at high risk for esophageal cancer. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 4485. doi:1538-7445.AM2012-4485

Abstract 4485: Prediction of Esophageal Cancer Risk Through Quantification of Gamma-H2ax Levels in Peripheral Blood Lymphocytes